Filing Details
- Accession Number:
- 0001209191-19-058376
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-11-27 19:11:19
- Reporting Period:
- 2016-11-26
- Accepted Time:
- 2019-11-27 19:11:19
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1340652 | Chemocentryx Inc. | CCXI | Pharmaceutical Preparations (2834) | 943254365 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1422995 | J. Markus Cappel | C/O Chemocentryx, Inc. 850 Maude Avenue Mountain View CA 94043 | Chief Bus. Officer & Treasurer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-11-26 | 64,323 | $6.30 | 99,764 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-11-26 | 48,697 | $6.90 | 148,461 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-11-26 | 24,348 | $10.27 | 172,809 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-11-26 | 123,156 | $14.31 | 295,965 | No | 4 | M | Direct | |
| Common Stock | Acquisiton | 2019-11-26 | 70,000 | $14.28 | 365,965 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-11-26 | 21,834 | $27.29 | 344,131 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-26 | 14,484 | $28.45 | 329,647 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-26 | 31,559 | $29.25 | 298,088 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-26 | 75,868 | $30.77 | 222,220 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-26 | 33,883 | $31.70 | 188,337 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-26 | 15,686 | $32.57 | 172,651 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-26 | 30,284 | $33.81 | 142,367 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-26 | 103,826 | $34.68 | 38,541 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-26 | 2,800 | $35.46 | 35,741 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-11-26 | 300 | $36.74 | 35,441 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (right to buy) | Disposition | 2019-11-26 | 64,323 | $0.00 | 64,323 | $6.30 |
| Common Stock | Stock Option (right to buy) | Disposition | 2019-11-26 | 48,697 | $0.00 | 48,697 | $6.90 |
| Common Stock | Stock Option (right to buy) | Disposition | 2019-11-26 | 24,348 | $0.00 | 24,348 | $10.27 |
| Common Stock | Stock Option (right to buy) | Disposition | 2019-11-26 | 123,156 | $0.00 | 123,156 | $14.31 |
| Common Stock | Stock Option (right to buy) | Disposition | 2019-11-26 | 70,000 | $0.00 | 70,000 | $14.28 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 0 | 2010-08-10 | 2020-08-10 | No | 4 | M | Direct |
| 0 | 2011-08-04 | 2021-08-04 | No | 4 | M | Direct |
| 0 | 2022-02-27 | No | 4 | M | Direct | |
| 0 | 2022-07-24 | No | 4 | M | Direct | |
| 0 | 2023-07-23 | No | 4 | M | Direct |
Footnotes
- The sales reported in this Form 4 were effected pursuant to a March 2019 Rule 10b5-1 trading plan adopted by the Reporting Person.
- Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $26.92 to $27.91 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $27.92 to $28.80 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the shares sold. The shares were sold in multiple trades at prices ranging from $28.94 to $29.93 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $30.12 to $31.11 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $31.12 to $32.08 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $32.12 to $33.11 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $33.14 to $34.10 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $34.16 to $35.04 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- Reflects the weighted average sale price of the sales sold. The shares were sold in multiple trades at prices ranging from $35.22 to $35.90 per share. The Reporting Person will provide to the SEC staff, the issuer or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
- As of November 26, 2019, and prior to this transaction, the exercised options were fully vested.
- Not applicable.
Billionaire Hedge Funds
